Amit Bar-Or
Company: University of Pennsylvania
Job title: Professor
Seminars:
Matching the Modality to the Disease: What Cell Therapy Type is Best for Which Indication? 9:00 am
As B cells are crucial to the pathogenesis of many autoimmune diseases, CD19 makes an attractive target because its expression is limited to those of a B-cell lineage. Additionally, the field has commonly developed therapies to treat indications such as lupus, multiple sclerosis, rheumatoid arthritis, and type 1 diabetes. But, what’s next for the field?…Read more
day: Pre-Conference Day